Safety, Pharmacokinetics, and Efficacy of AI-081, a Bispecific Antibody for PD-1 And VEGF in Advanced Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kai He, MD, PhD
The Ohio State University James Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham, Alabama, United States
Recruiting - Highlands Oncology Group
Springdale, Arkansas, United States
Recruiting - Medstar Georgetown University Hospital
Washington D.C., District of Columbia, United States
Recruiting - University of Florida Uf Health Cancer Center
Gainesville, Florida, United States
Recruiting - Memorial Healthcare System
Hollywood, Florida, United States
Recruiting - Ocala Oncology Center Pl Dba Florida Cancer Affiliates
Ocala, Florida, United States
Recruiting - Adventhealth Cancer Institute
Orlando, Florida, United States
Recruiting - Northwestern University
Chicago, Illinois, United States
Recruiting - Norton Cancer Center
Louisville, Kentucky, United States
Recruiting - Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Recruiting - University of Michigan Rogel Cancer Center
Ann Arbor, Michigan, United States
Recruiting - Henry Ford Health
Detroit, Michigan, United States
Recruiting - the Tisch Cancer Institute, Mount Sinai Medical Center
New York, New York, United States
Not, yet, recruiting - University of North Carolina at Chapel Hill Cancer Center
Chapel Hill, North Carolina, United States
Recruiting - Novant Health Cancer Institute
Winston-Salem, North Carolina, United States
Recruiting - the Ohio State University James Cancer Center
Columbus, Ohio, United States
Recruiting - Prisma Health
Greenville, South Carolina, United States
Recruiting - Md Anderson Cancer Center
Houston, Texas, United States
Recruiting - University of Utah Huntsman Cancer Institute
Salt Lake City, Utah, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Mar 2025
- Primary completion
- 30 Jun 2027
- Completion
- 31 Dec 2027
- Last update posted
- 9 Apr 2026
- Registered enrollment
- 387
- Registry id
- NCT06635785
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.